Literature DB >> 8608482

Benefits versus risks from mammography: a critical reassessment.

F A Mettler1, A C Upton, C A Kelsey, R N Ashby, R D Rosenberg, M N Linver.   

Abstract

BACKGROUND: The use of mammography has increased rapidly over the last decade. The justification for mammographic examinations is the potential benefit they provide in detecting breast cancer at an early stage and reducing mortality. However, this benefit must be balanced against the associated potential risk of radiation carcinogenesis, economic costs, and a number of other factors. Most publications to date have used radiation risk factors and data from studies that were published over a decade ago, which now have been superseded by the results of more recent epidemiological studies.
METHODS: This report examines the current literature regarding the benefits of cancer detection and the risk of radiation carcinogenesis, and calculates the ratio of benefit and risk for women who begin annual mammography screening at different ages. We have used current data to calculate the expected individual benefits and radiation risks associated with annual mammographic screening.
RESULTS: It now appears that there is little risk of breast cancer associated with radiation exposure from annual mammography in women over the age of 35, although there is some indication that exposure of younger women may pose a risk for those women in a genetically sensitive subgroup.
CONCLUSIONS: New data document that for a woman beginning annual mammographic screening at age 50 and continuing until age 75, the benefit exceeds the radiation risk by a factor of almost 100. Even for a woman who begins annual screening at age 35 and continues until age 75, the benefit of reduced mortality is projected to exceed the radiation risk by factor of more than 25.

Entities:  

Mesh:

Year:  1996        PMID: 8608482

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

Review 1.  Evidence based case report: Advice about mammography for a young woman with a family history of breast cancer.

Authors:  A Lucassen; E Watson; D Eccles
Journal:  BMJ       Date:  2001-04-28

Review 2.  Applications of Advanced Breast Imaging Modalities.

Authors:  Arwa A Alzaghal; Pamela J DiPiro
Journal:  Curr Oncol Rep       Date:  2018-05-29       Impact factor: 5.075

Review 3.  Genomic Biomarkers for Breast Cancer Risk.

Authors:  Michael F Walsh; Katherine L Nathanson; Fergus J Couch; Kenneth Offit
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

4.  Cancer-related risk indicators and preventive screening behaviors among lesbians and bisexual women.

Authors:  S D Cochran; V M Mays; D Bowen; S Gage; D Bybee; S J Roberts; R S Goldstein; A Robison; E J Rankow; J White
Journal:  Am J Public Health       Date:  2001-04       Impact factor: 9.308

Review 5.  The contribution of epigenetic changes to abnormal centrosomes and genomic instability in breast cancer.

Authors:  J L Salisbury
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-04       Impact factor: 2.673

Review 6.  Breast MR imaging in women at high-risk of breast cancer. Is something changing in early breast cancer detection?

Authors:  Francesco Sardanelli; Franca Podo
Journal:  Eur Radiol       Date:  2006-09-29       Impact factor: 5.315

Review 7.  Mammary ductoscopy in the current management of breast disease.

Authors:  Sarah S K Tang; Dominique J Twelves; Clare M Isacke; Gerald P H Gui
Journal:  Surg Endosc       Date:  2010-12-18       Impact factor: 4.584

8.  Modern breast cancer detection: a technological review.

Authors:  Adam B Nover; Shami Jagtap; Waqas Anjum; Hakki Yegingil; Wan Y Shih; Wei-Heng Shih; Ari D Brooks
Journal:  Int J Biomed Imaging       Date:  2009-12-28

9.  Knowledge and attitude towards screening mammography among 400 women in the eastern province of saudi arabia.

Authors:  F A Al-Mulhim
Journal:  J Family Community Med       Date:  2001-09

10.  5th Milan Breast Cancer Conference, Milan, Italy, 11-13 June 2003.

Authors:  Manuel Oscar Gomez Cuadra
Journal:  Breast Cancer Res       Date:  2003-07-28       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.